New targets for schizophrenia treatment beyond the dopamine hypothesis

AC Yang, SJ Tsai - International journal of molecular sciences, 2017 - mdpi.com
Schizophrenia has been primarily associated with dopamine dysfunction, and treatments
have been developed that target the dopamine pathway in the central nervous system …

Linking inflammation, aberrant glutamate-dopamine interaction, and post-synaptic changes: translational relevance for schizophrenia and antipsychotic treatment: a …

A de Bartolomeis, A Barone, L Vellucci, B Mazza… - Molecular …, 2022 - Springer
Evidence from clinical, preclinical, and post-mortem studies supports the
inflammatory/immune hypothesis of schizophrenia pathogenesis. Less evident is the link …

Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain

A De Rosa, A Fontana, T Nuzzo, M Garofalo, A Di Maio… - Schizophrenia, 2022 - nature.com
Schizophrenia is a disorder of synaptic plasticity and aberrant connectivity in which a major
dysfunction in glutamate synapse has been suggested. However, a multi-level approach …

The role of G protein-coupled receptors (GPCRs) and calcium signaling in schizophrenia. Focus on GPCRs activated by neurotransmitters and chemokines

T Boczek, J Mackiewicz, M Sobolczyk, J Wawrzyniak… - Cells, 2021 - mdpi.com
Schizophrenia is a common debilitating disease characterized by continuous or relapsing
episodes of psychosis. Although the molecular mechanisms underlying this psychiatric …

Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice

F Guida, L Luongo, F Marmo, R Romano, M Iannotta… - Molecular brain, 2015 - Springer
Background Enhanced supraspinal glutamate levels following nerve injury are associated
with pathophysiological mechanisms responsible for neuropathic pain. Chronic pain can …

Drug design targeting the muscarinic receptors and the implications in central nervous system disorders

CR Johnson, BD Kangas, EM Jutkiewicz, J Bergman… - Biomedicines, 2022 - mdpi.com
There is substantial evidence that cholinergic system function impairment plays a significant
role in many central nervous system (CNS) disorders. During the past three decades …

Mechanisms underpinning Carpolobia lutea G. Don ethanol extract's neurorestorative and antipsychotic-like activities in an NMDA receptor antagonist model of …

NA Omeiza, A Bakre, B Ben-Azu, AA Sowunmi… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Persistent ketamine insults to the central nervous system
block NMDA receptors and disrupt putative neurotransmission, oxido–nitrosative, and …

Rational and translational implications of D-amino acids for treatment-resistant schizophrenia: from neurobiology to the clinics

A de Bartolomeis, L Vellucci, MC Austin, G De Simone… - Biomolecules, 2022 - mdpi.com
Schizophrenia has been conceptualized as a neurodevelopmental disorder with synaptic
alterations and aberrant cortical–subcortical connections. Antipsychotics are the mainstay of …

Dysregulations of synaptic vesicle trafficking in schizophrenia

CN Egbujo, D Sinclair, CG Hahn - Current psychiatry reports, 2016 - Springer
Schizophrenia is a serious psychiatric illness which is experienced by about 1% of
individuals worldwide and has a debilitating impact on perception, cognition, and social …

Treating the synapse in major psychiatric disorders: the role of postsynaptic density network in dopamine-glutamate interplay and psychopharmacologic drugs …

C Tomasetti, F Iasevoli, EF Buonaguro… - International Journal of …, 2017 - mdpi.com
Dopamine-glutamate interplay dysfunctions have been suggested as pathophysiological
key determinants of major psychotic disorders, above all schizophrenia and mood disorders …